Real-world adherence, persistence, and health care resource utilization among people with HIV receiving long-acting cabotegravir plus rilpivirine compared with oral antiretroviral therapy in the United States: The ABOVE Study.
- DOI
- 10.18553/jmcp.2026.32.5.584
- Published
- 2026 May
- Container
- Journal of managed care & specialty pharmacy
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.18553/jmcp.2026.32.5.584,
title = {Real-world adherence, persistence, and health care resource utilization among people with HIV receiving long-acting cabotegravir plus rilpivirine compared with oral antiretroviral therapy in the United States: The ABOVE Study.},
author = {Garris C and DerSarkissian M and Chang R and Clear L and Chen Z and Liu D and Desai R and Teichner P and Overton ET},
year = {2026},
journal = {Journal of managed care \& specialty pharmacy},
doi = {10.18553/jmcp.2026.32.5.584},
url = {https://doi.org/10.18553/jmcp.2026.32.5.584}
}RIS
TY - JOUR TI - Real-world adherence, persistence, and health care resource utilization among people with HIV receiving long-acting cabotegravir plus rilpivirine compared with oral antiretroviral therapy in the United States: The ABOVE Study. AU - Garris C AU - DerSarkissian M AU - Chang R AU - Clear L AU - Chen Z AU - Liu D AU - Desai R AU - Teichner P AU - Overton ET PY - 2026 JO - Journal of managed care & specialty pharmacy DO - 10.18553/jmcp.2026.32.5.584 UR - https://doi.org/10.18553/jmcp.2026.32.5.584 ER -
APA
C, G., M, D., R, C., L, C., Z, C., D, L., R, D., P, T., & ET, O. (2026). Real-world adherence, persistence, and health care resource utilization among people with HIV receiving long-acting cabotegravir plus rilpivirine compared with oral antiretroviral therapy in the United States: The ABOVE Study.. Journal of managed care & specialty pharmacy. https://doi.org/10.18553/jmcp.2026.32.5.584
Source records
- pubmed · retrieved 2026-09-25T17:52:09.079Z
- europe-pmc · retrieved 2026-09-25T17:52:09.111Z